Power Doppler Ultrasonography Assessment of Entheses in Spondyloarthropathies: Response to Therapy of Entheseal Abnormalities


Por: Naredo, E, Batlle-Gualda, E, Garcia-Vivar, ML, Garcia-Aparicio, AM, Fernandez-Sueiro, JL, Fernandez-Prada, M, Giner, E, Rodriguez-Gomez, M, Pina, MF, Medina-Luezas, JA, Toyos, FJ, Campos, C, Gutierrez-Polo, R, Ferrer, MA, Martinez, O, Diaz-Torne, C, Gonzalez, T, Campos, S, Queiro, R, Castano-Sanchez, M, Aznar, JJ, Bustabad, S, Paez-Camino, M, Tuneu, R, Ruiz, T, Mateo, L, Pujol, M, Ponce, A, Ros, I, Gallegos, A, Moreno, J, Gumbau, D, Sianes, M, Poveda-Elices, MJ, Romero-Gomez, M, Raya, E

Publicada: 1 oct 2010
Resumen:
Objective. To investigate the response to therapy of entheseal abnormalities assessed with power Doppler (PD) ultrasound (US) in spondyloarthropathies (SpA). Methods. A total of 327 patients with active SpA who were starting anti-tumor necrosis factor (TNF) therapy were prospectively recruited at 35 Spanish centers. A PDUS examination of 14 peripheral entheses was performed by the same investigator in each center at baseline and at 6 months. The following elementary lesions were assessed at each enthesis (presence/absence): morphologic abnormalities (hypoechogenicity and/or thickening), entheseal calcific deposits, cortical abnormalities (bone erosion and/or proliferation), adjacent bursitis and intraenthesis and perienthesis (tendon body and/or bursa) PD signal. Response to therapy of each elementary lesion was assessed by calculating change in the cumulative presence from baseline to 6 months. Intraobserver reliability of PDUS was evaluated by blindly assessing the stored baseline images 3 months after the real-time examination. Results. Complete data were obtained on 197 patients who received anti-TNF therapy for 6 months. In 91.4% of the patients there were gray-scale or PD elementary lesions at baseline and at 6 months. Cumulative entheseal morphologic abnormalities, intraenthesis PD, perienthesis PD, and bursitis showed a significant decrease from baseline to 6 months (p < 0.05). There was high intraobserver reliability for all elementary lesions (interclass correlation coefficient > 0.90, p < 0.0005). Conclusion. Entheseal morphologic abnormalities. PD signal, and bursitis were US abnormalities that were responsive to anti-TNF therapy in SpA. PDUS can be a reproducible method for multicenter monitoring of therapeutic response in enthesitis of SpA. (First Release September 1 2010; J Rheumatol 2010:37:2110-17; doi:10.3899/jrheum.100136)

Filiaciones:
Naredo, E:
 Hosp Univ Severn Ochoa, Dept Rheumatol, Madrid 28033, Spain

Batlle-Gualda, E:
 Hosp Univ Alicante, Alicante, Spain

Garcia-Vivar, ML:
 Hosp Basurto, Bilbao, Spain

Garcia-Aparicio, AM:
 Hosp Virgen Salud, Toledo, Spain

Fernandez-Sueiro, JL:
 Hosp Juan Canalejo, La Coruna, Spain

Fernandez-Prada, M:
 Hosp Univ Guadalajara, Guadalajara, Spain

Giner, E:
 Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

Rodriguez-Gomez, M:
 Complejo Hosp Ourense, Orense, Spain

Pina, MF:
 Hosp Rafael Mendez, Murcia, Spain

Medina-Luezas, JA:
 Complejo Hosp Palencia, Palencia, Spain

Toyos, FJ:
 Hosp Virgen Macarena, Seville, Spain

Campos, C:
 Hosp Gen Univ Valencia, Valencia, Spain

Gutierrez-Polo, R:
 Clin San Miguel, Pamplona, Spain

Ferrer, MA:
 Hosp Univ Virgen de la Nieves, Granada, Spain

Martinez, O:
 Hosp Virgen de la Concha, Zamora, Spain

Diaz-Torne, C:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Gonzalez, T:
 Inst Prov Rehabil, Madrid, Spain

Campos, S:
 Hosp Virgen del Rocio, Seville, Spain

Queiro, R:
 Hosp Univ Cent Asturias, Oviedo, Spain

Castano-Sanchez, M:
 Hosp Virgen Arrixaca, Merida, Venezuela

Aznar, JJ:
 Hosp Merida, Merida, Venezuela

Bustabad, S:
 Hosp Univ Tenerife, Tenerife, Spain

Paez-Camino, M:
 Hosp Jerez, Jerez de la Frontera, Spain

Tuneu, R:
 Hosp Althaia Xarsa Assistencial Manresa, Barcelona, Spain

Ruiz, T:
 Hosp Sierrallana, Santander, Spain

Mateo, L:
 Hosp Badalona Germans Trias & Pujol, Badalona, Spain

Pujol, M:
 Hosp Mutua de Terrassa, Barcelona, Spain

Ponce, A:
 Hosp Gen Granollers, Barcelona, Spain

Ros, I:
 Hosp Son Llatzer, Palma De Mallorca, Spain

Gallegos, A:
 Hosp Univ Getafe, Madrid, Spain

Moreno, J:
 Hosp Santa Maria del Rosell, Cartagena, Spain

Gumbau, D:
 Hosp de la Plana, Villarreal, Spain

Sianes, M:
 Hosp Gen Albacete, Albacete, Spain

Poveda-Elices, MJ:
 Hosp Univ Tarragona Joan XXIII, Tarragona, Spain

Romero-Gomez, M:
 Hosp Univ Reina Sofia, Cordoba, Spain

Raya, E:
 Hosp Clin San Cecilio, Granada, Spain
ISSN: 0315162X





JOURNAL OF RHEUMATOLOGY
Editorial
J RHEUMATOL PUBL CO, 365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA, Canada
Tipo de documento: Article
Volumen: 37 Número: 10
Páginas: 2110-2117
WOS Id: 000282864400021
ID de PubMed: 20810495

MÉTRICAS